Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07225283

Developing Resiliency and Exercise Using AI-based Messaging

Developing Resiliency and Exercise Using AI-based Messaging: The DREAM Pilot Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the DREAM program, an 8-week message-based intervention to promote physical activity and well-being in adults with type 2 diabetes.

Detailed description

This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the DREAM program. DREAM is an 8-week message-based program to promote physical activity and well-being in adults with type 2 diabetes. In DREAM, participants will complete twice weekly messaging sessions, in which they will set weekly physical activity goals and perform activities to enhance well-being. The primary outcome is feasibility (measured by number of messaging sessions successfully transmitted) and acceptability (measured by 0-10 utility ratings). Secondary outcomes include preliminary impact on physical activity and psychological and health-related outcomes.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDREAMParticipants will engage in twice weekly messaging sessions and will work towards a physical activity goal each week for a total of eight weeks.

Timeline

Start date
2026-04-01
Primary completion
2027-03-31
Completion
2027-03-31
First posted
2025-11-06
Last updated
2026-02-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07225283. Inclusion in this directory is not an endorsement.